Insider screener

Period: 12 months + Add filter
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

59,448 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

59,448 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

59,448 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

59,448 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
59,448 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
59,448 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

59,448 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
8 Jan 2026
Chin-Chi Teng Sr. Vice President
Sold on a plan
$2.01M 6,319 at 317.96
5.1%
Planned (10b5-1)
8 Jan 2026
Sold on a plan 6×
$1.71M 26,190 at 65.47
29.3%
Planned (10b5-1)
8 Jan 2026
Sold on a plan
$1.66M 52,864 at 31.32
100%
Sold half or more
8 Jan 2026
Jonathan M Rothberg Director · indirect
Sold on a plan
$1.40M 335,834 at 4.18
100%
Sold half or more
8 Jan 2026
William Joseph Brennan Pres & Chief Executive Officer
Sold on a plan 8×
$1.32M 9,476 at 139.54
3.4%
Planned (10b5-1)
8 Jan 2026
Russell Wayne Ford Chief Executive Officer · indirect
Sold on a plan
$1.23M 40,000 at 30.76
4.5%
Planned (10b5-1)
8 Jan 2026
Scott Farquhar Director · indirect also filed by Michael Cannon-Brookes
Sold on a plan 9×
$1.16M 7,665 at 151.87
1.8%
Planned (10b5-1)
8 Jan 2026
Barry H Golsen Director · indirect
Sold on a plan 3×
$1.09M 118,953 at 9.19
55.1%
Sold half or more
8 Jan 2026
Mark D. McClain Chief Executive Officer
Sold on a plan
$1.03M 52,799 at 19.57
0.7%
Planned (10b5-1)
8 Jan 2026
Stanley Hills LLC 10% owner
Sold at will
$993.71K 82,261 at 12.08
2.2%
Not planned
8 Jan 2026
Joseph P Lyssikatos Chief Scientific Officer · indirect
Sold on a plan 2×
$993.44K 41,302 at 24.05
4.6%
Planned (10b5-1)
8 Jan 2026
Saba Capital Management, L.P. 10% owner · indirect
Sold at will
$942.13K 69,325 at 13.59
1.3%
Not planned
8 Jan 2026
Richard A Hayne CEO & Chairman of the Board
Sold on a plan 5×
$881.25K 10,667 at 82.61
0.1%
Planned (10b5-1)
8 Jan 2026
David M Carter President, DRSS Division
Sold on a plan 8×
$856.19K 8,123 at 105.40
9.0%
Planned (10b5-1)
8 Jan 2026
Martina M.D. Flammer Chief Medical Officer
Sold on a plan 2×
$854.85K 4,911 at 174.07
5.4%
Planned (10b5-1)
8 Jan 2026
Lei Wu Chief Executive Officer · indirect
Sold on a plan 2×
$829.27K 20,000 at 41.46
2.4%
Planned (10b5-1)
8 Jan 2026
Bayview Legacy, LLC 10% owner · indirect also filed by K Charles Janac
Sold on a plan
$829.16K 50,000 at 16.58
0.5%
Planned (10b5-1)
8 Jan 2026
Daniel Dines CEO and Chairman
Sold on a plan
$787.19K 45,000 at 17.49
0.2%
Planned (10b5-1)
8 Jan 2026
Richard A Hayne CEO & Chairman of the Board · indirect also filed by Margaret Hayne
Sold on a plan 5×
$771.05K 9,333 at 82.62
0.4%
Planned (10b5-1)
8 Jan 2026
Laurie Siegel Director
Sold at will 2×
$761.94K 2,572 at 296.25
71.3%
Sold half or more
8 Jan 2026
Forager Fund, L.P. 10% owner
Sold at will
$709.62K 18,294 at 38.79
1.7%
Not planned
8 Jan 2026
Daniel Faga President, CEO
Sold at will
$638.50K 14,281 at 44.71
2.9%
Not planned
8 Jan 2026
Brian Carolan Chief Financial Officer
Sold on a plan
$599.62K 30,638 at 19.57
2.3%
Planned (10b5-1)
8 Jan 2026
William Lewis Chair and CEO
Sold at will
$561.35K 3,223 at 174.17
1.0%
Not planned
8 Jan 2026
Daniel W. Fleming Chief Financial Officer
Sold on a plan
$546.87K 3,902 at 140.15
0.9%
Planned (10b5-1)
8 Jan 2026
Thomas Taira President, Special Projects
Sold on a plan
$524.78K 1,174 at 447.00
1.7%
Planned (10b5-1)
8 Jan 2026
Nieuwenhuyse Rick Van President & CEO
Sold at will
$509.81K 19,608 at 26.00
3.5%
Not planned
8 Jan 2026
Mark Ragosa Chief Financial Officer
Sold on a plan
$502.68K 12,000 at 41.89
38.6%
Planned (10b5-1)
8 Jan 2026
Leon O Moulder Jr Chief Executive Officer
Bought
$489.00K 30,000 at 16.30
9.5%
8 Jan 2026
Jessica A. Garascia Senior VP, GC, CAO & Secretary
Sold at will
$455.98K 4,787 at 95.25
13.9%
Not planned
8 Jan 2026
Chad Roberts EVP, Production Solutions
Sold on a plan
$453.13K 23,428 at 19.34
12.1%
Planned (10b5-1)
8 Jan 2026
Jeffrey W Dunn Director · indirect
Sold on a plan
$425.51K 20,000 at 21.28
20.0%
Planned (10b5-1)
8 Jan 2026
Katherine H Ramundo EVP, CLO, CCO & Secretary
Sold on a plan
$425.00K 5,000 at 85.00
4.1%
Planned (10b5-1)
8 Jan 2026
Stacey G Rock President, KTT Division
Sold on a plan 7×
$421.49K 4,000 at 105.37
8.5%
Planned (10b5-1)
8 Jan 2026
Mario Schlosser President of Technology & CTO
Sold on a plan
$406.62K 23,038 at 17.65
6.2%
Planned (10b5-1)
8 Jan 2026
Sold on a plan 2×
$406.54K 28,924 at 14.06
3.5%
Planned (10b5-1)
8 Jan 2026
John Michael Wilson Chief Quality Officer and CTO
Sold at will
$375.60K 5,000 at 75.12
7.7%
Not planned
8 Jan 2026
Kyle Kline Senior Vice President, CFO
Sold on a plan
$363.35K 3,594 at 101.10
100%
Sold half or more
8 Jan 2026
Roger Adsett Chief Operating Officer
Sold at will
$358.62K 2,059 at 174.17
1.9%
Not planned
8 Jan 2026
Eric Pauwels Chief Business Officer
Sold on a plan 3×
$352.06K 4,602 at 76.50
5.3%
Planned (10b5-1)
8 Jan 2026
Laura A Williams Chief Patient Officer
Sold on a plan
$348.90K 50,000 at 6.98
12.1%
Planned (10b5-1)
8 Jan 2026
Jacob DeWitte Co-Founder, CEO · indirect also filed by Caroline Cochran
Sold on a plan 3×
$345.54K 3,455 at 100.01
0.4%
Planned (10b5-1)
8 Jan 2026
Mark Elliott Boulding Exec. VP and CLO
Sold on a plan 3×
$308.76K 4,033 at 76.56
3.4%
Planned (10b5-1)
8 Jan 2026
Corey J Manley EVP&Chief Legal/Admin Officer
Sold on a plan
$304.69K 6,106 at 49.90
6.2%
Planned (10b5-1)
Showing 47,951–48,000 of 59,448. ← Newer Page 960 of 1,189 Older →